Loading clinical trials...

Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT05039983

Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer

The main symptom of patients with advanced esophageal cancer is eating obstruction. In clinical practice, patients need to wait for a long time before anti-tumor treatment, which will lead to a rapid ...

Lead sponsor: Shandong Cancer Hospital and Institute•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Point of Care Ultrasound for the Detection of Esophageal Food Bolus

NCT06507670 · Esophageal Foreign Body, Esophageal Obstruction

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 3, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment18

Start dateAug 2021

Last updatedApr 3, 2024

Condition

Esophageal Obstruction

Locations shown

Shan Dong cancer hospital and institute

Jinan, Shandong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 3, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions